Pharmaterials are continuing to experience strong growth in the full range of services that they provide. As a result new staff have been appointed including a solid oral dosage form formulation expert, an experienced inhalation scientist and an experienced analyst. Each of these new staff members have excellent industrial experience and academic track records, coming from big-pharma and contract research companies to join Pharmaterials.
Professor Graham Buckton (Chief Executive Officer of Pharmaterials) said "We have seen strong demand for all of our service offerings with continued year on year growth in revenues. We pride ourselves on customer focus and excellent communication, to support high quality science, which results in repeat business and word of mouth recommendation. We have been able to invest in more new instruments and greatly increase staff numbers to twice what we were a year ago. I am delighted to see this reinvestment to further strengthen the service we can offer.”
Additionally Pharmaterials now seek a scientist / senior scientist to join our screening group to match the rapid business expansion (see careers page on this site).
At the present time Pharmaterials have no fewer than 5 vacancies to support company expansion and are always interested to hear from dynamic people seeking a new challenge in their career. |
